(Q24234164)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22161409%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

meta-analysis

0 references

title

Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22161409%20AND%20SRC:MED&resulttype=core&format=json

chronic obstructive pulmonary disease

18 January 2020

main subject

0 references

author

Sally Spencer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22161409%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Christopher Cates

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22161409%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Charlotta Karner

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22161409%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

David J Evans

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22161409%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

language of work or name

English

0 references

publication date

7 December 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22161409%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

18 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22161409%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22161409%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

CD007033

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22161409%20AND%20SRC:MED&resulttype=core&format=json

Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease

18 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007033.PUB3

Cost effectiveness of budesonide/formoterol in a single inhaler for COPD compared with each monocomponent used alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007033.PUB3

The efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007033.PUB3

Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007033.PUB3

Relationship between respiratory symptoms and medical treatment in exacerbations of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007033.PUB3

Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007033.PUB3

Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007033.PUB3

The TORCH (towards a revolution in COPD health) survival study protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007033.PUB3

Development of an economic model to assess the cost effectiveness of treatment interventions for chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007033.PUB3

Early onset of effect of salmeterol and fluticasone propionate in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007033.PUB3

Gender does not influence the response to the combination of salmeterol and fluticasone propionate in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007033.PUB3

Inhaled salmeterol/fluticasone propionate combination in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007033.PUB3

Budesonide/formoterol: in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007033.PUB3

Inhaled corticosteroids vs placebo for preventing COPD exacerbations: a systematic review and metaregression of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007033.PUB3

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007033.PUB3

Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007033.PUB3

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007033.PUB3

Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007033.PUB3

Safety of long-acting beta-agonists in stable COPD: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007033.PUB3

Safety and efficacy of combined long-acting beta-agonists and inhaled corticosteroids vs long-acting beta-agonists monotherapy for stable COPD: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007033.PUB3

Time course of recovery of health status following an infective exacerbation of chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007033.PUB3

Inhaled corticosteroids for stable chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007033.PUB3

Statistical analysis of exacerbation rates in COPD: TRISTAN and ISOLDE revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007033.PUB3

Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007033.PUB3

Is treatment with ICS and LABA cost-effective for COPD? Multinational economic analysis of the TORCH study.

21 January 2018

1 reference

12 December 2020

Efficacy and safety of budesonide and formoterol in one pressurized metered-dose inhaler in patients with moderate to very severe chronic obstructive pulmonary disease: results of a 6-month randomized clinical trial

1 reference

12 December 2020

TORCH study results: pharmacotherapy reduces lung function decline in patients with chronic obstructive pulmonary disease

1 reference

12 December 2020

Combined corticosteroid and long-acting beta-agonist in one inhaler versus long-acting beta-agonists for chronic obstructive pulmonary disease

1 reference

12 December 2020

Sex Differences in Mortality and Clinical Expressions of Patients with Chronic Obstructive Pulmonary Disease

1 reference

12 December 2020

[Clinical study of the month: the TORCH study (TOwards a Revolution in COPD Health)]

1 reference

12 December 2020

An evaluation of salmeterol in the treatment of chronic obstructive pulmonary disease (COPD)

1 reference

12 December 2020

Combined corticosteroid and long-acting beta-agonist in one inhaler versus inhaled steroids for chronic obstructive pulmonary disease

1 reference

12 December 2020

Quality of life changes in COPD patients treated with salmeterol

1 reference

12 December 2020

Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease

1 reference

12 December 2020

An overview of the benefits and drawbacks of inhaled corticosteroids in chronic obstructive pulmonary disease

1 reference

12 December 2020

Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD Health study

1 reference

12 December 2020

Methods for therapeutic trials in COPD: lessons from the TORCH trial.

1 reference

12 December 2020

Cardiovascular events in patients with COPD: TORCH study results

1 reference

12 December 2020

Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society

1 reference

12 December 2020

Health Status Deterioration in Patients with Chronic Obstructive Pulmonary Disease

1 reference

12 December 2020

Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society

1 reference

12 December 2020

Inhalation combination therapy in chronic obstructive lung disease. TRISTAN-study

1 reference

12 December 2020

Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease

1 reference

12 December 2020

Combined corticosteroid and long-acting beta-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease

1 reference

12 December 2020

Bias due to withdrawal in long-term randomised trials in COPD: evidence from the TORCH study.

1 reference

12 December 2020

10.1002/14651858.CD007033.PUB3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22161409%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22161409%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference